SCHEMBL1785668

SCHEMBL1785668

NC(=O)c1cc(N2CCOCC2)ccc1Cl

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.54
LMNA P02545 2/20 0.54
HTT P42858 2/20 0.54
ALDH1A1 P00352 1/20 0.54
HPGD P15428 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
MCL1 Q07820 1/20 0.53
KDM4E B2RXH2 2/20 0.52
GAA P10253 2/20 0.52
RAB9A P51151 2/20 0.52
NPC1 O15118 1/20 0.52
POLB P06746 1/20 0.52
JAK2 O60674 2/20 0.52
PRKDC P78527 3/20 0.51
JAK1 P23458 1/20 0.48
TYK2 P29597 1/20 0.48
JAK3 P52333 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3656262 0.92 MAPT (0.47) MAPTLMNAHTTALDH1A1HPGD
SCHEMBL4351617 0.86 PRKDC (0.59) MAPTHTTALDH1A1MEN1KMT2A
SCHEMBL1785344 0.86 MAPT (0.58) MAPTLMNAHTTALDH1A1HPGD
SCHEMBL144733 0.83 LGMN (0.59) MAPTJAK2PRKDCJAK1TYK2
SCHEMBL552259 0.83 PRKDC (0.60) MAPTJAK2PRKDCJAK1TYK2
SCHEMBL29039888 0.82 MAPT (0.51) MAPTLMNAHTTALDH1A1MEN1
SCHEMBL3228970 0.82 MAPT (0.56) MAPTHTTALDH1A1HPGDMEN1
SCHEMBL1786156 0.82 MAPT (0.54) MAPTLMNAHTTALDH1A1HPGD
SCHEMBL1785810 0.81 MAPT (0.59) MAPTLMNAHTTALDH1A1HPGD
SCHEMBL29151160 0.81 MAPT (0.52) MAPTLMNAHTTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130203730-A1 BENZOTHIAZOLES AS GHRELIN RECEPTOR MODULATORS ASTRAZENECA AB (SE) 2013-08-08 US disclosed
EP-2607357-A1 BENZOTHIAZOLES AS GHRELIN RECEPTOR MODULATORS Astrazeneca AB (SE) 2013-06-26 EP disclosed
US-20120115845-A1 THERAPEUTIC AGENTS ALLEN JACK MCQUEEN (GB) 2012-05-10 US disclosed
US-20110124621-A1 BENZOTHIAZOLES AS GHRELIN RECEPTOR MODULATORS ASTRAZENECA AB (SE) 2011-05-26 US disclosed
CN-101883762-A Benzothiazoles as modulators of growth hormone releasing hormone receptors ASTRAZENECA AB 2010-11-10 CN disclosed
EP-2205576-A1 BENZOTHIAZOLES AS GHRELIN RECEPTOR MODULATORS AstraZeneca AB (SE) 2010-07-14 EP disclosed
US-20090186870-A1 Therapeutic Agents - 802 ASTRAZENECA AB (SE) 2009-07-23 US disclosed
WO-2009047558-A1 BENZOTHIAZOLES AS GHRELIN RECEPTOR MODULATORS ASTRAZENECA AB (SE) 2009-04-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130203730-A1 BENZOTHIAZOLES AS GHRELIN RECEPTOR MODULATORS GPR119, GHSR, GLP1R MAPT 3413/4885LMNA 4721/4885HTT 509/4885
US-20120115845-A1 THERAPEUTIC AGENTS GPR119, MC2R, MC4R MAPT 4086/4885LMNA 4327/4885HTT 1903/4885
US-20090186870-A1 Therapeutic Agents - 802 GPR119, SLC5A2, MC2R MAPT 4300/4885LMNA 4113/4885HTT 2295/4885
US-20110124621-A1 BENZOTHIAZOLES AS GHRELIN RECEPTOR MODULATORS GPR119, GHSR, GLP1R MAPT 3413/4885LMNA 4721/4885HTT 509/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.